Title:
VIRAL INFECTION PREVENTING AGENT
Document Type and Number:
WIPO Patent Application WO/2024/010035
Kind Code:
A1
Abstract:
Provided is a viral infection preventing agent containing methyl hesperidin as an active ingredient. Also provided is a method for using the viral infection preventing agent, the method including applying the viral infection preventing agent onto the surface of an article. Also provided is a method for using the viral infection preventing agent, the method including spraying the viral infection preventing agent over the body surface of an animal. Also provided is a method for using the viral infection preventing agent, the method including spraying or blending the viral infection preventing agent over fibers or into the fibers. Also provided is a viral infection preventing composition comprising the viral infection preventing agent and a pharmaceutically acceptable carrier.
Inventors:
NAKAGAMI YUKO (JP)
Application Number:
PCT/JP2023/024948
Publication Date:
January 11, 2024
Filing Date:
July 05, 2023
Export Citation:
Assignee:
RESONAC CORP (JP)
International Classes:
A01N43/16; A01P1/00; A61K9/12; A61K31/7028; A61K31/7048; A61P31/12
Foreign References:
| KR20040065864A | 2004-07-23 | |||
| JP2018058769A | 2018-04-12 | |||
| JP2020125246A | 2020-08-20 | |||
| JP2014114290A | 2014-06-26 |
Other References:
HAGGAG, Y. A. et al. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?. Medical Hypotheses, 2020, vol. 144, pp. 1-3
BHOWMIK DEEP, NANDI RAJAT, PRAKASH AMRESH, KUMAR DIWAKAR: "Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis", HELIYON, ELSEVIER LTD, GB, vol. 7, no. 3, 1 March 2021 (2021-03-01), GB , pages 1 - 13, XP055882995, ISSN: 2405-8440, DOI: 10.1016/j.heliyon.2021.e06515
BHOWMIK DEEP, NANDI RAJAT, PRAKASH AMRESH, KUMAR DIWAKAR: "Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis", HELIYON, ELSEVIER LTD, GB, vol. 7, no. 3, 1 March 2021 (2021-03-01), GB , pages 1 - 13, XP055882995, ISSN: 2405-8440, DOI: 10.1016/j.heliyon.2021.e06515
Attorney, Agent or Firm:
OIKAWA Shu et al. (JP)
Download PDF: